Health ❯ Healthcare ❯ Public Health ❯ Infectious Diseases

Influenza

FDA Reverses Course To Review Moderna’s mRNA Flu Shot Under Split Pathway

The reversal follows a rare refusal-to-file over the trial comparator for seniors, with a decision due August 5.

Massachusetts Confirms Seventh Pediatric Flu Death as U.S. Toll Climbs

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

Flu Toll Rises in New England: 6 Pediatric Deaths in Mass., 35 Total in N.H.

Virginia Reports First Child Flu Death During Brief National Lull in Severe H3N2 Season

U.S. Flu Metrics Dip Slightly, but H3N2 Wave Keeps Pressure on Hospitals

Flu Hospital Numbers Rebound in England as NHS Warns Winter Pressures Intensify

Flu Visits Hit Record Levels as Drifted H3N2 Variant Drives Early U.S. Surge

Flu Surge Accelerates Nationwide as New York Sets Weekly Hospitalization Record

Flu Hospitalizations Double as H3N2 Subclade K Drives Early U.S. Surge

New H3N2 ‘Subclade K’ Drives Early U.S. Flu Surge as New York Sets Weekly Case Record

Flu Season Accelerates as H3N2 Subclade K Becomes Dominant in the U.S.

Flu Surges Nationwide as H3N2 Subclade K Dominates, Straining Hospitals Before Holidays

WHO Says Early H3N2 ‘Subclade K’ Flu Wave Is Straining Hospitals Across Europe

LA and Riverside Counties Report First Flu Deaths of 2025–26 Season

Cidara’s CD388 Antiviral Achieves Up to 76% Flu Protection in Phase 2b Trial